Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for THYROCARE TECHNOLOGIES
Please provide your vote to see the results

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -50.5844.251.919.71-2.14

What is the latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES is -50.58 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-50.58
Mar202244.25
Mar20211.91
Mar20209.71
Mar2019-2.14

How is Core EBITDA Growth of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2023 -50.58
Negative
Mar2022 44.25
2,216.75
Mar2021 1.91
-80.33
Mar2020 9.71
Positive
Mar2019 -2.14 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹3,440.0 Cr -0.7% 4.4% 40.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹85,581.4 Cr 1.7% -1.8% 30.8% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹81,699.0 Cr 3.7% 9% 65.8% Stock Analytics
GLOBAL HEALTH ₹38,124.0 Cr -0.6% 2.5% 147.8% Stock Analytics
FORTIS HEALTHCARE ₹34,041.1 Cr 1.7% 3.8% 63.8% Stock Analytics
NARAYANA HRUDAYALAYA ₹26,421.8 Cr 3.5% 4.2% 71.1% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

-0.7%

4.4%

40.8%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses